A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy
Open Access
- 22 May 2013
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 24 (9) , 2349-2353
Abstract
Whether carcinomas of the ampulla of Vater should be classified with biliary tract tumors and treated in a similar manner remains unknown. We sought to compare the outcomes of similarly staged periampullary adenocarcinomas (AAs) and analyze the chemotherapy responsiveness of AAs. A total of 905 patients with resected periampullary adenocarcinomas were identified from a prospective surgical registry from 1988 to 2010. A second cohort of 64 metastatic AA patients from 1992 to 2009 who received either front-line fluoropyrimidine-based or gemcitabine-based chemotherapy was also identified. Overall survival (OS) for AAs was similar to survival with duodenal adenocarcinomas, but was significantly different from both extrahepatic biliary and pancreatic adenocarcinomas (P < 0.001 for each comparison). In multivariate analysis, AAs had a significantly improved OS in comparison with extrahepatic biliary adenocarcinomas (HR = 1.97, P = 0.006). Fluoropyrimidine-based as opposed to gemcitabine-based chemotherapy for metastatic AAs resulted in a significant improvement in time to progression (P = 0.001) but only a trend toward benefit for OS (P = 0.07) in multivariate analysis. Differences in the natural history of ampullary and extrahepatic biliary adenocarcinomas exist. Analyses of metastatic ampullary adenocarcinomas suggest that fluoropyrimidine-based chemotherapy may represent a more appropriate front-line chemotherapy approach.Keywords
This publication has 17 references indexed in Scilit:
- Phenotypic and Genotypic Characterization of Carcinomas of the Papilla of Vater Has Prognostic and Putative Therapeutic ImplicationsAmerican Journal of Clinical Pathology, 2011
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Cancers of the ampulla of vater: Demographics, morphology, and survival based on 5,625 cases from the SEER programJournal of Surgical Oncology, 2009
- Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinomaBMC Cancer, 2008
- Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancerAnnals of Oncology, 2008
- Expression of the Caudal-Type Homeodomain Transcription Factors CDX 1/2 and Outcome in Carcinomas of the Ampulla of VaterJournal of Clinical Oncology, 2005
- Phase II Study of 5-fluorouracil, Doxorubicin, and Mitomycin C for Metastatic Small Bowel AdenocarcinomaThe Oncologist, 2005
- Pathogenesis of carcinoma of the papilla of VaterJournal of Hepato-Biliary-Pancreatic Surgery, 2004
- Periampullary AdenocarcinomaAnnals of Surgery, 1998
- Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of VaterJapanese Journal of Cancer Research, 1994